{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:18:59Z","timestamp":1790392739808,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalspathology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.anndiagpath.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T17:27:50Z","timestamp":1476206870000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Benjamin B.","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Kelting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-9718","authenticated-orcid":false,"given":"Robin D.","family":"LeGallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharin","family":"Pramoonjago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8228-4091","authenticated-orcid":false,"given":"Teresa A.","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Heitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine S.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0005","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","article-title":"PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma","volume":"88","author":"Rosenberg","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0010","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.2009.140","article-title":"Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms","volume":"23","author":"Chen","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/PAI.0000000000000067","article-title":"Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders","volume":"22","author":"Nakashima","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1309\/BDR959TT4JU6388C","article-title":"Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival","volume":"125","author":"Cook","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0030","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/modpathol.3880239","article-title":"Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia","volume":"13","author":"Miranda","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","article-title":"A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus","volume":"129","author":"Ehinger","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","article-title":"SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma","volume":"61","author":"Hsiao","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0000000000000120","article-title":"Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements","volume":"38","author":"Juskevicius","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0050","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/cncr.28664","article-title":"Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"120","author":"Ok","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/AJCPIVKZRMPF93ET","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression","volume":"138","author":"Gradowski","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0060","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/modpathol.3800183","article-title":"Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells","volume":"17","author":"Bai","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0065","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood-2002-04-1128","article-title":"Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays","volume":"101","author":"Garcia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.1279","article-title":"High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1","volume":"199","author":"Tzankov","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/his.12446","article-title":"Sequential immunohistochemistry: a promising new tool for the pathology laboratory","volume":"65","author":"van den Brand","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0080","series-title":"WHO Classificiation of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"202","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0085","doi-asserted-by":"crossref","first-page":"e78812","DOI":"10.1371\/journal.pone.0078812","article-title":"Nodular lymphocyte predominant hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?","volume":"8","author":"Hartmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0090","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3324\/haematol.2009.016931","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma","volume":"95","author":"Pittaluga","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0095","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Boudova","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-4608(86)90212-8","article-title":"Cytogenetic findings in nodular paragranuloma (Hodgkin's disease with lymphocytic predominance; nodular) and in progressively transformed germinal centers","volume":"21","author":"Hansmann","year":"1986","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0105","first-page":"298","article-title":"Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease","volume":"84","author":"Falzetti","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-4608(98)00204-0","article-title":"Chromosome aberrations in adult Hodgkin disease in a Danish population-based study","volume":"110","author":"Pedersen","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0115","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/sj.leu.2404736","article-title":"Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"21","author":"Stamatoullas","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0120","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood.V97.6.1845","article-title":"Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances","volume":"97","author":"Franke","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0125","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)64462-8","article-title":"Comparative genomic hybridization pattern distinguishes T-cell\/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma","volume":"161","author":"Franke","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2559.1999.00662.x","article-title":"Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method?","volume":"34","author":"Chan","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0135","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2007-10-120824","article-title":"Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression","volume":"111","author":"Herens","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.10.003_bb0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","article-title":"EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T15:21:09Z","timestamp":1536333669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913416302775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":28,"alternative-id":["S1092913416302775"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.10.003","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}